{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:04:03Z","timestamp":1791633843465,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis vaccine development is hindered by the lack of validated immune correlates of protection. Exploring immune correlates of risk of disease and\/or infection in prospective samples can inform this field. We investigate whether previously identified immune correlates of risk of TB disease also associate with increased risk of\n                    <jats:italic>M.tb<\/jats:italic>\n                    infection in BCG-vaccinated South African infants, who became infected with\n                    <jats:italic>M.tb<\/jats:italic>\n                    during 2-3 years of follow-up.\n                    <jats:italic>M.tb<\/jats:italic>\n                    infection is defined by conversion to positive reactivity in the QuantiFERON test. We demonstrate that inflammation and immune activation are associated with risk of\n                    <jats:italic>M.tb<\/jats:italic>\n                    infection. Ag85A-specific IgG is elevated in infants that were subsequently infected with\n                    <jats:italic>M.tb<\/jats:italic>\n                    , and this is coupled with upregulated gene expression of immunoglobulin-associated genes and type-I interferon. Plasma levels of IFN-\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\alpha$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mi>\u03b1<\/mml:mi>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    2, TNF-\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\alpha$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mi>\u03b1<\/mml:mi>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    , CXCL10 (IP-10) and complement C2 are also higher in infants that were subsequently infected with\n                    <jats:italic>M.tb<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-34061-7","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T09:02:51Z","timestamp":1667466171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants"],"prefix":"10.1038","volume":"13","author":[{"given":"Iman","family":"Satti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-5635","authenticated-orcid":false,"given":"Rachel E.","family":"Wittenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuailin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-7726","authenticated-orcid":false,"given":"Deniz","family":"Cizmeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7476-9715","authenticated-orcid":false,"given":"Nicola","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-1006","authenticated-orcid":false,"given":"Helen A.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-1359","authenticated-orcid":false,"given":"Thomas J.","family":"Scriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7983-7203","authenticated-orcid":false,"given":"Michele","family":"Tameris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3491-1809","authenticated-orcid":false,"given":"Mark","family":"Hatherill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-5142","authenticated-orcid":false,"given":"Helen","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"34061_CR1","unstructured":"World Health Organisation (WHO). Global tuberculosis report. https:\/\/www.who.int\/publications\/i\/item\/9789240037021. 2021;WHO Report."},{"key":"34061_CR2","doi-asserted-by":"crossref","unstructured":"Dheda K. et al. The immunology of tuberculosis: From bench to bedside. Respirology. John Wiley & Sons, Ltd; 2010. 433\u2013450. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1440-1843.2010.01739.x.","DOI":"10.1111\/j.1440-1843.2010.01739.x"},{"key":"34061_CR3","doi-asserted-by":"crossref","unstructured":"Barry C. E. et al. The spectrum of latent tuberculosis: Rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 845\u2013855 (2020).","DOI":"10.1038\/nrmicro2236"},{"key":"34061_CR4","doi-asserted-by":"crossref","unstructured":"Mangtani P. et al. Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials. Clin. Infect. Dis. 58, 470\u2013480 (2014).","DOI":"10.1093\/cid\/cit790"},{"key":"34061_CR5","doi-asserted-by":"crossref","unstructured":"Tameris M. D. M. et al. Safety and effi cacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet. 381, 1021\u20131028 (2013).","DOI":"10.1016\/S0140-6736(13)60177-4"},{"key":"34061_CR6","unstructured":"Fletcher H. A., et al. T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat. Commun 7, 2706 (2016)."},{"key":"34061_CR7","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","volume":"387","author":"DE Zak","year":"2016","unstructured":"Zak, D. E. et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 387, 2312\u20132322 (2016).","journal-title":"Lancet"},{"key":"34061_CR8","unstructured":"Wittkop L. Effect of cytomegalovirus-induced immune response, self antigen-induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV type 1-infected patients: the ANRS CO3 Aquitaine Cohort. J. Infect. Dis. 207:622\u2013627 (2013)."},{"key":"34061_CR9","first-page":"3944","volume":"90","author":"S Gianella","year":"2016","unstructured":"Gianella, S. et al. Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV. Infection 90, 3944\u20133952 (2016).","journal-title":"Infection"},{"key":"34061_CR10","doi-asserted-by":"crossref","unstructured":"Klenerman P., Hill A. T cells and viral persistence: lessons from diverse infections Paul. Nat. Publish. Group 22, 873\u2013879 (2015)().","DOI":"10.1038\/ni1241"},{"key":"34061_CR11","unstructured":"M\u00fcller J., et al. Cytomegalovirus infection is a risk factor for tuberculosis disease in infants Julius. JCI Insight American Society for Clin. Invest. 5, 130090 (2019)."},{"key":"34061_CR12","first-page":"1127","volume":"221","author":"L Stockdale","year":"2020","unstructured":"Stockdale, L. et al. Cytomegalovirus antibody responses associated with increased risk of tuberculosis disease in ugandan adults. J. Infect. Dis. 221, 1127\u20131134 (2020).","journal-title":"J. Infect. Dis."},{"key":"34061_CR13","doi-asserted-by":"crossref","unstructured":"Martinez L., et al. Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa. Lancet. Glob. Heal. 9, e1740\u2013e1749 (2021).","DOI":"10.1016\/S2214-109X(21)00407-1"},{"key":"34061_CR14","unstructured":"Mulenga H., et al. Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis. Am. J. Respir. Crit. Care Med. https:\/\/pubmed.ncbi.nlm.nih.gov\/34520313 (2021)."},{"key":"34061_CR15","doi-asserted-by":"crossref","unstructured":"Evans T. G., et al. Epidemiologic studies and novel clinical research approaches that impact TB vaccine development. Tuberculosis Churchill Livingstone. S21\u2013S25 (2016).","DOI":"10.1016\/j.tube.2016.05.008"},{"key":"34061_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/14760584.2019.1593143","volume":"18","author":"AM Ginsberg","year":"2019","unstructured":"Ginsberg, A. M. Designing tuberculosis vaccine efficacy trials\u2013lessons from recent studies. Expert Rev. Vaccines. 18, 423\u2013432 (2019).","journal-title":"Expert Rev. Vaccines."},{"key":"34061_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","volume":"379","author":"E Nemes","year":"2018","unstructured":"Nemes, E. et al. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. N. Engl. J. Med. 379, 138\u2013149 (2018).","journal-title":"N. Engl. J. Med."},{"key":"34061_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","volume":"191","author":"JR Andrews","year":"2015","unstructured":"Andrews, J. R. et al. The dynamics of QuantiFERON-TB Gold in-Tube conversion and reversion in a cohort of South African adolescents. Am. J. Respir. Crit. Care Med. 191, 584\u2013591 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"34061_CR19","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1128\/JCM.43.9.4713-4718.2005","volume":"43","author":"SC Munro","year":"2005","unstructured":"Munro, S. C. et al. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J. Clin. Microbiol. 43, 4713\u20134718 (2005).","journal-title":"J. Clin. Microbiol."},{"key":"34061_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","volume":"15","author":"S Li","year":"2014","unstructured":"Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195\u2013204 (2014).","journal-title":"Nat. Immunol."},{"key":"34061_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fmicb.2015.01016","volume":"6","author":"E Adland","year":"2015","unstructured":"Adland, E. et al. Ongoing burden of disease and mortality from HIV\/CMV coinfection in Africa in the antiretroviral therapy era. Front. Microbiol. 6, 1016 (2015).","journal-title":"Front. Microbiol."},{"key":"34061_CR22","unstructured":"Berry MPRR, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Matthew. Nature. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20725040 (2010)."},{"key":"34061_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/BF02184687","volume":"9","author":"M Segondy","year":"1990","unstructured":"Segondy, M. et al. Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infection. Eur. J. Clin. Microbiol. Infect. Dis. 9, 745\u2013750, (1990).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"34061_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/655472","volume":"202","author":"PJ Van De Berg","year":"2010","unstructured":"Van De Berg, P. J. et al. Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J. Infect. Dis. 202, 690\u2013699 (2010).","journal-title":"J. Infect. Dis."},{"key":"34061_CR25","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1097\/QAD.0b013e32833016e8","volume":"23","author":"JA Slyker","year":"2009","unstructured":"Slyker, J. A. et al. Acute cytomegalovirus infection in Kenyan HIV-infected infants. AIDS 23, 2173\u20132181 (2009).","journal-title":"AIDS"},{"key":"34061_CR26","unstructured":"Scriba T. J., et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog. 13, 1\u201324 (2017)."},{"key":"34061_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1126\/science.277.5329.1091","volume":"277","author":"JS Schorey","year":"1997","unstructured":"Schorey, J. S., Carroll, M. C. & Brown, E. J. A macrophage invasion mechanism of pathogenic mycobacteria. Sci. (80-.). 277, 1091\u20131093 (1997).","journal-title":"Sci. (80-.)."},{"key":"34061_CR28","unstructured":"Ivashkiv L. B., Donlin L. T. Regulation of type i interferon responses. Nat. Rev. Immunol. 2014. \/pmc\/articles\/PMC4084561\/?report=abstract."},{"key":"34061_CR29","unstructured":"Xu W., et al. Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection. Immunity. https:\/\/pubmed.ncbi.nlm.nih.gov\/33515487 (2021)."},{"key":"34061_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1128\/CVI.00128-14","volume":"21","author":"SA Harris","year":"2014","unstructured":"Harris, S. A. et al. Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85A. Clin. Vaccin. Immunol. 21, 1005\u20131011 (2014).","journal-title":"Clin. Vaccin. Immunol."},{"key":"34061_CR31","doi-asserted-by":"crossref","unstructured":"Lamble S. et al. Improved workflows for high throughput library preparation using the transposome-based nextera system. BMC Biotechnol. https:\/\/pubmed.ncbi.nlm.nih.gov\/24256843 (2013).","DOI":"10.1186\/1472-6750-13-104"},{"key":"34061_CR32","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D. et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915, (2019).","journal-title":"Nat. Biotechnol."},{"key":"34061_CR33","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"34061_CR34","doi-asserted-by":"crossref","unstructured":"Love M. I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. https:\/\/pubmed.ncbi.nlm.nih.gov\/25516281 (2014).","DOI":"10.1101\/002832"},{"key":"34061_CR35","unstructured":"Weiner J., Domaszewska T. tmod: an R package for general and multivariate enrichment analysis. 2016. Available from: https:\/\/peerj.com\/preprints\/2420."},{"key":"34061_CR36","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"S Carbon","year":"2019","unstructured":"Carbon, S. et al. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330\u2013D338 (2019).","journal-title":"Nucleic Acids Res."},{"key":"34061_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G. et al. ClusterProfiler: An R package for comparing biological themes among gene clusters. Omi. A J. Integr. Biol. 16, 284\u2013287 (2012).","journal-title":"Omi. A J. Integr. Biol."},{"key":"34061_CR38","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/bioinformatics\/btm087","volume":"23","author":"JZ Wang","year":"2007","unstructured":"Wang, J. Z. et al. A new method to measure the semantic similarity of GO terms. Bioinformatics 23, 1274\u20131281 (2007).","journal-title":"Bioinformatics"},{"key":"34061_CR39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","volume":"26","author":"G Yu","year":"2010","unstructured":"Yu, G. et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26, 976\u2013978 (2010).","journal-title":"Bioinformatics"},{"key":"34061_CR40","doi-asserted-by":"crossref","unstructured":"Gu Z. & H\u00fcbschmann D. Simplify enrichment: A bioconductor package for clustering and visualizing functional enrichment results. Genomics. Proteomics Bioinformatics. 2022.","DOI":"10.1016\/j.gpb.2022.04.008"},{"key":"34061_CR41","doi-asserted-by":"publisher","first-page":"e0187901","DOI":"10.1371\/journal.pone.0187901","volume":"12","author":"H Sanz","year":"2017","unstructured":"Sanz, H. et al. drLumi: An open-source package to manage data, calibrate, and conduct quality control of multiplex bead-based immunoassays data analysis. PLoS One 12, e0187901 (2017).","journal-title":"PLoS One"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34061-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T09:03:36Z","timestamp":1667466216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34061-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34061"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34061-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1632594\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"assertion":[{"value":"7 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.M. was previously a shareholder in the Oxford-Emergent Tuberculosis Consortium (OETC), a joint venture established for the development of MVA85A (OETC no longer exists). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6594"}}